Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 ,inter alia, to consider and approve Annual Financial Results ....
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Life Sciences has informed the exchanges that its Board of Directors will meet on May 13, 2025 to consider and approve the audited standalone and consolidated financial results for the quarter and full financial year ended March 31, 2025. The Board will also consider a proposal to raise funds by issuing equity shares, warrants, convertible securities, or other instruments, potentially through a qualified institutions placement (QIP) or preferential allotment, subject to shareholder and regulatory approvals. The trading window for insiders is closed from April 1, 2025 until May 15, 2025. No financial figures or detailed terms of the fund raise have been disclosed in this notice.
Investors should watch for the Q4/FY25 results announcement on May 13 for performance clarity. The mention of a possible equity fund raise could lead to short-term dilution concerns, depending on the size and price of the issue.